Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-159402
Filing Date
2015-04-30
Accepted
2015-04-30 09:03:16
Documents
9
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d786327ddefa14a.htm DEFA14A 34421
2 GRAPHIC g786327dsp_001a.jpg GRAPHIC 64621
3 GRAPHIC g786327dsp_001b.jpg GRAPHIC 41434
4 GRAPHIC g786327dsp_001c.jpg GRAPHIC 20602
5 GRAPHIC g786327dsp_001d.jpg GRAPHIC 32945
6 GRAPHIC g786327dsp_001e.jpg GRAPHIC 20705
7 GRAPHIC g786327dsp_001f.jpg GRAPHIC 14279
8 GRAPHIC g786327dsp_001g.jpg GRAPHIC 16577
9 GRAPHIC g786327dsp_001h.jpg GRAPHIC 15770
  Complete submission text file 0001193125-15-159402.txt   349584
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19311 | Film No.: 15815538
SIC: 2836 Biological Products, (No Diagnostic Substances)